<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02122055</url>
  </required_header>
  <id_info>
    <org_study_id>CMATJHICU</org_study_id>
    <nct_id>NCT02122055</nct_id>
  </id_info>
  <brief_title>Sequential Use of Propofol/Midazolam and Dexmedetomidine for Sedation in Mechenical Ventialtion Patients in ICU.</brief_title>
  <official_title>Sequential Use of Propofol/Midazolam and Dexmedetomidine for Sedation in Mechenical Ventialtion Patients in ICU, A Randomized Controlled Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tianjin Third Central Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Chinese Medical Association</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Tianjin Third Central Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      For the patient who passed the screen of weaning from ventilation, the traditional sedation
      drug such as propofol and midazolam should be decreased or stopped, then it would induce the
      stress response and agitation, such as hypertension,tachycardia etc. In order to resolve that
      problem, the sedation should be given again. but if renewed to sedation, it would cause
      prolonged sedation and ventilation duration.

      So as to resolve above issues, after the patient passed the screen of weaning, sedation is
      changed to Dexmedetomidine, a new sedation drug, that could wake up at any time. So our study
      to compare the efficacy and safety of sequential sedation of propofol or midazolam and
      dexmedetomidine in mechanical ventilated ICU patients.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>June 2014</start_date>
  <completion_date type="Anticipated">April 2015</completion_date>
  <primary_completion_date type="Anticipated">April 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Ventilation duration</measure>
    <time_frame>From intubation to weaning from mechanical ventilation, up to 7 days.</time_frame>
    <description>The time of intubation and the time of weaning from mechanical ventilation are recorded.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Delirium</measure>
    <time_frame>From the beginning of sedation to discharge from ICU, up to 28 days.</time_frame>
    <description>Using the Mini-mental State Examination(MMSE) to examine the delirium.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood pressure</measure>
    <time_frame>From the beginning to weaning of sedation, up to 7 days.</time_frame>
    <description>blood pressure is recorded.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cost of sedation drug</measure>
    <time_frame>From the admition to discharge from ICU,up to 28 days.</time_frame>
    <description>The cost of sedation drug is calculated.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cost of narcotics</measure>
    <time_frame>From the admition to discharge from ICU,up to 28 days.</time_frame>
    <description>Cost of narcotics is calculated.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cost of ICU stay</measure>
    <time_frame>From the beginning to weaning of sedation, up to 7 days.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart rate</measure>
    <time_frame>From the beginning to weaning of sedation, up to 7 days.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Respiration Rate</measure>
    <time_frame>From the beginning to weaning of sedation, up to 7 days.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pulse blood oxygen saturation</measure>
    <time_frame>From the beginning to weaning of sedation, up to 7 days.</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Mechanical Ventilation Complication</condition>
  <arm_group>
    <arm_group_label>Propofol/Dexmedetomidine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Propofol is started with dosage of 0.3 mg/kg/h, observe the patient's response, increase 0.3 mg/kg/h propofol every 10 minutes until target sedation level is obtained(Riker Sedation Agitation Score(SAS) 3-4),then 0.3-3 mg/kg/h propofol is maintained.
After the screen of the weaning is passed, change to Dexmedetomidine sedation, the dose is 0.2-0.7 mg/kg/h and continuously pumped, increase the dose 0.1-0.2 mg/kg/h every 30 minutes, titrate to Riker Sedation Agitation Score(SAS) 3-4，the maximum dose is 1 mg/kg/h maintained，and prepare for weaning.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Midazolam/Dexmedetomidine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Midazolam 2 mg is slowly titrated to Riker Sedation Agitation Score(SAS) 3-4 every 10 minutes, then Midazolam 0.02-0.1 mg/kg/h is maintained.
After the screen of the weaning is passed, change to Dexmedetomidine sedation, the dose is 0.2-0.7 mg/kg/h and continuously pumped, increase the dose 0.1-0.2 mg/kg/h every 30 minutes, titrate to Riker Sedation Agitation Score(SAS) 3-4，the maximum dose is 1 mg/kg/h maintained，and prepare for weaning.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fentanyl</intervention_name>
    <description>Fentanyl 0.7-1μg/kg，prn pain assessment is done every 4 hours，maintain Behavioral Pain Scale（BPS） 0-2.</description>
    <arm_group_label>Propofol/Dexmedetomidine</arm_group_label>
    <arm_group_label>Midazolam/Dexmedetomidine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Sedation assessment</intervention_name>
    <description>Sedation assessment is done every 4 hours,maintain the Riker Sedation Agitation Score(SAS) 3-4.</description>
    <arm_group_label>Propofol/Dexmedetomidine</arm_group_label>
    <arm_group_label>Midazolam/Dexmedetomidine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Screen of weaning</intervention_name>
    <description>1. Screen of weaning is done at 8:00 every morning. 2 If the patient is successful to wean, stop the Dexmedetomidine sedation. 3. If failed to wean, the patient is ventilated again and try to wean after 24 hours, until it is successful to wean and stop sedation，</description>
    <arm_group_label>Propofol/Dexmedetomidine</arm_group_label>
    <arm_group_label>Midazolam/Dexmedetomidine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Propofol</intervention_name>
    <description>Propofol is started with dosage of 0.3 mg/kg/h, observe the patient's response, increase 0.3 mg/kg/h propofol every 10 minutes until target sedation level is obtained(Riker Sedation Agitation Score(SAS) 3-4),then 0.3-3 mg/kg/h propofol is maintained.</description>
    <arm_group_label>Propofol/Dexmedetomidine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Midazolam</intervention_name>
    <description>Midazolam 2 mg is slowly titrated to Riker Sedation Agitation Score(SAS) 3-4 every 10 minutes, then Midazolam 0.02-0.1 mg/kg/h is maintained.</description>
    <arm_group_label>Midazolam/Dexmedetomidine</arm_group_label>
    <other_name>Liyuexi</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexmedetomidine</intervention_name>
    <description>After the screen of the weaning is passed, change to Dexmedetomidine sedation, the dose is 0.2-0.7 mg/kg/h and continuously pumped, increase the dose 0.1-0.2 mg/kg/h every 30 minutes, titrate to Riker Sedation Agitation Score(SAS) 3-4，the maximum dose is 1 mg/kg/h maintained，and prepare for weaning.</description>
    <arm_group_label>Propofol/Dexmedetomidine</arm_group_label>
    <arm_group_label>Midazolam/Dexmedetomidine</arm_group_label>
    <other_name>Yisi</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Written Informed Consent

          2. Anticipated Ventilation and sedation duration of at least 48 hours

          3. Age≥18 years old

          4. Weight is in the range of ±20% of standard weight.[Standard weight=
             (Height(cm)-80)×70﹪ for male and (Height(cm)-70)×60﹪for female] -

        Exclusion Criteria:

          1. Extremely unstable of circulatory system, such as systolic blood pressure less than 90
             mm Hg despite continuous infusions of vasopressors before the start of study drug
             infusion or shock；

          2. Heart rate less than 50 bpm

          3. Second or third degree heart block

          4. Serious central nervous system pathology(acute stroke, uncontrolled seizures,severe
             dementia)

          5. Acute hepatitis or severe liver disease (Child-Pugh class C)

          6. Dialysis of all types 7）History of neuromuscular disease

        8) Unstable mental status and metal illness 9) Sure or suspected abuse of narcotics and
        alcohol independence 10) Allergy to experimental drug and other contraindication 11)
        Advanced tumor patients 12) Neuromuscular blockade other than for intubation 13) Pregnancy
        or lactation 14) Patient that participate other trial at past 30 days -
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jun Li, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tianjin Third Central Hospital</affiliation>
  </overall_official>
  <verification_date>April 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 21, 2014</study_first_submitted>
  <study_first_submitted_qc>April 22, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 24, 2014</study_first_posted>
  <last_update_submitted>April 22, 2014</last_update_submitted>
  <last_update_submitted_qc>April 22, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 24, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>combined sedation</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Dexmedetomidine</mesh_term>
    <mesh_term>Midazolam</mesh_term>
    <mesh_term>Fentanyl</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

